
ABOUT CYTEL
Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value and make confident, evidence-based decisions. Our experts deliver industry-leading software, data-driven analytics, real-world evidence and strategic consulting. Headquartered in Waltham, Massachusetts, Cytel has more than 1,400 employees across North America, Europe and Asia. For more information about Cytel, please visit us at www.cytel.com. You also can follow us on LinkedIn and Twitter and like us on Facebook.
CONTACT INFORMATION
Cytel
1050 Winter Street
Waltham, MA 02451
UNITED STATES
Contact: Rebecca Grimm
FEATURED ARTICLES
-
Discover The Sufficient Information Threshold: a conceptual point that can enable us to begin asking questions about the efficiency, ethical quality and effectiveness of a clinical study.
-
Learn how new technology can be harnessed to answer an array of questions about early stopping, the pacing of interim analyses, enrollment variability and cost-optimization.
-
Systematic literature reviews (SLRs) are essential for proving product value, yet very often, the speed of scientific discovery outpaces the ability of researchers to integrate new insights into existing SLRs. Discover a new approach that ensures the most recent science is quickly incorporated into industry research programs.
-
Clinical development professionals are faced with many questions to answer and problems to solve during the product development expedition. What clinical trial design will provide the right answers at the right time? How can it be accomplished quickly and economically?
-
This white paper delves into one of the critical questions facing trial planners: "Can we recruit the required number of patients (e.g., 1000) within the assigned time (e.g., 25 months)?"
-
In this eBook, learn about the key elements of planning a clinical data strategy for the entire duration of a development program, specifically for Phase 1 and Phase 2 trials.
-
A small biotech sponsor developing a new treatment for carcinoma asked for assistance with their trial design. Working with a constrained R&D budget, the challenge was to gather the evidence in as cost effective a manner as possible and use a stage-gate approach for the funding. Explore the solutions uncovered in the available case study.
-
Gain insight into how providing sponsors with an efficient way to consider a large number of clinical trial design options can help ensure that effective drugs have the best opportunity to demonstrate their value and reach the market in a timely fashion.
BROCHURES
- Designed For Results
- Solara Software For Optimizing Clinical Trial Design
- East Bayes For Clinical Trial Design
- Solara Software Platform For Clinical Trials
- East® Version 6.5
- Transform Real-World Data Into Real-World Evidence
- Oncology Clinical Development Services
- Independent Statistical Center Function
- From Trial Design To CDISC Submission
- Data Science Brochure
- Quantitative Pharmacology and Pharmacometrics Brochure
- Cytel East Architect Brochure
- EnForeSys Enrollment Forecasting Software Brochure
- Cytel Services Brochure